Apellis Pharmaceuticals Inc (APLS)

Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell

$16.50

Buy

$17.59

arrow-down$-0.48 (-2.76%)

Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is engaged in the discovery and development of novel therapeutic compounds for autoimmune and inflammatory diseases.
Prices updated at 30 May 2025, 22:56 EDT
| Prices minimum 15 mins delay
|
Prices in USD
NASDAQ
arrow-down-0.32%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
$17.37 - $16.69
$43.76 - $16.10
-
2,127.80m
-
-
3,416,274
12.96
2,273,072.78
-0.33
124.50m
US03753U1060
-1.80
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.